PDE4A and chronic obstructive pulmonary disease: PDE4 has been shown to be an effective therapeutic target for distinct inflammatory conditions, including asthma, chronic obstructive pulmonary disease (COPD), psoriasis, atopic dermatitis (AD), inflammatory bowel disease (IBD), rheumatic arthritis (RA), and neuroinflammation [5,6,7].